Umhlanga buying Heroin

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Umhlanga buying Heroin

Stephen is a founding shareholder of the Aspen Group and his responsibilities include strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company. He also assesses business performance and identifies business improvement opportunities. Kuseni is the Chairman of Massmart Holdings Limited. She chairs or serves on the audit committees of these boards and also serves on a number of their other board committees. She was previously a member of numerous South African and international standard setting, oversight and corporate governance structures. Ben joined Standard Merchant Bank in and, after having fulfilled various leadership roles in corporate and investment banking, was appointed as Chief Executive of Standard Bank Corporate and Investment Banking in Independent Non-executive B. Eng Hons April Chris has been a full-time practising attorney since and has substantial legal and commercial expertise. His intimate knowledge of the Group, its business operations and governance processes have been of immense benefit to Aspen over the years and he continues to serve the Board as a trusted adviser. Independent Non-executive D. Yvonne completed her D. She is widely published and has written and edited several books, articles and international conference papers. Neo is a Chartered Accountant with B. Com and B. After serving her articles and qualifying as a chartered accountant at Deloitte, Neo proceeded to join Gensec Asset Management where she spent her early career as an equity analyst. She later rejoined Deloitte where she held the position of audit partner for almost 9 years. She is currently a non-executive director on the board of Nedbank Limited. Neo was previously Chair of Barloworld Limited and the Takeover Regulation Panel, and also served on various listed and unlisted boards across multiple industries and jurisdictions. He joined Glaxo in in finance and progressed through a series of finance roles before becoming Finance Director of the European business in ViiV is a joint venture between GSK, Pfizer and Shionogi and focuses specifically on the research and development and global commercialisation of medicines to treat HIV. Gus is a founding shareholder of Aspen and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and our stakeholders. Lorraine is responsible for multiple operational areas of the business, including strategic manufacturing, pharmaceutical affairs, new product development and strategic procurement. In addition, she plays an integral role in negotiation and implementation of new business initiatives for the Manufacturing business, which she also represents in global transactions. Samer joined the Group with the responsibility of establishing the company to lead and direct its international operations. Zizipho is responsible for focusing on assessing and implementing strategic development activities for the Group such as acquisitions, disposals and business development collaborations. She also plays an active role in advancing business performance and value enhancement opportunities. Senior Executive Strategic Trade B. He plays a leading role in all transactional activity in the region. Fact Sheet 1 file s Aspen Holdings www. We Care. Excellence Integrity Healthcare. Innovation Commitment Teamwork. FY Results Presentation View the online version and select download options. Our Heritage. With a year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have more than 9 employees at 65 established offices in over 50 countries and we improve the health of patients in more than countries through our high quality, affordable medicines. Aspen focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through our key business segments. Our manufacturing capabilities cover a wide variety of product types including steriles, oral solid dose, liquids, semi-solids, biologicals and active pharmaceutical ingredients. We operate 23 manufacturing facilities across 15 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines. Learn More. Investor Hub. Register For Alerts. Stephen Saad Classification: Qualification: Appointment:. Further Information Stephen is a founding shareholder of the Aspen Group and his responsibilities include strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company. Sean Capazorio Reginald Haman Kuseni Dlamini Linda de Beer Ben Kruger Further Information Ben joined Standard Merchant Bank in and, after having fulfilled various leadership roles in corporate and investment banking, was appointed as Chief Executive of Standard Bank Corporate and Investment Banking in Themba Mkhwanazi Chris Mortimer Further Information Chris has been a full-time practising attorney since and has substantial legal and commercial expertise. Yvonne Muthien Neo Phakama Dongwana David Redfern Gus Attridge Further Information Gus is a founding shareholder of Aspen and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and our stakeholders. Lorraine Hill Further Information Lorraine is responsible for multiple operational areas of the business, including strategic manufacturing, pharmaceutical affairs, new product development and strategic procurement. Samer Kassem Further Information Samer joined the Group with the responsibility of establishing the company to lead and direct its international operations. Zizipho Mmango Further Information Zizipho is responsible for focusing on assessing and implementing strategic development activities for the Group such as acquisitions, disposals and business development collaborations. Stavros Nicolaou Carnie van der Linde Trevor Ziman Annual Results Annual Financial Statements 1 file s 1 MB. Annual Results Booklet 1 file s Results Booklet — Excel Downloads 1 file s Annual Results Presentation Webcast 1 file s View Online. Annual Results Short Form Announcement 1 file s Annual Results Presentation 1 file s 5. Illustrative Revenue Disclosure 1 file s Environmental Management Policy 1 file s Carbon Disclosure Project — Climate Change 1 file s Carbon Disclosure Project — Water Security 1 file s Equity Report — Pharmacare Workforce Profile 1 file s Aspen Key Facts. Press Releases. Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships Read More. Find out more. To improve the health and quality of life of patients. To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally. Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group. Facebook-f Twitter-square Instagram Linkedin. About Aspen. Careers at Aspen Aspen Jobs. Contact Us. Closed Period. The live presentation will take place in Cape Town at 08h30 on 2 March